Heme metabolism as a therapeutic target against protozoan parasites.
Guilherme Curty LechugaMirian Claudia de Souza PereiraSaulo C BourguignonPublished in: Journal of drug targeting (2018)
Neglected tropical diseases caused by protozoan parasites affect the life of millions of people worldwide, causing mortality, morbidity and high economic and social burden. The search for new drug targets and therapeutic strategies to fight these pathogens are necessary, since many current drugs have limited effects, cause severe side effects and their use has resulted in pathogen resistance. Heme (iron protoporphyrin IX) is a ubiquitous molecule important in many biological processes, including the homeostasis, growth and development of human pathogens such as trypanosomatids (Trypanosoma cruzi, Trypanosoma brucei and Leishmania spp.) and Plasmodium spp. In this review, several chemotherapy approaches and strategies are discussed that target heme transport, catabolism, crystallization and hemeproteins.
Keyphrases
- plasmodium falciparum
- trypanosoma cruzi
- gram negative
- endothelial cells
- healthcare
- antimicrobial resistance
- risk factors
- mental health
- drug induced
- cardiovascular events
- induced pluripotent stem cells
- locally advanced
- type diabetes
- multidrug resistant
- candida albicans
- pluripotent stem cells
- squamous cell carcinoma
- coronary artery disease
- emergency department
- iron deficiency